Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Longitude Position in a Time Zone and Cancer Risk-Response.

Caporaso NE, Gu F, Klerman EB, Devesa SS, Jones RR, Zhang F, Cahoon EK, Graubard BI.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1111-1112. doi: 10.1158/1055-9965.EPI-17-1199. No abstract available.

PMID:
30181322
2.

Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.

Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, Devesa SS, Thun MJ.

N Engl J Med. 2018 May 24;378(21):1999-2009. doi: 10.1056/NEJMoa1715907.

PMID:
29791813
3.

Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data.

Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R.

Int J Epidemiol. 2018 Apr 1;47(2):427-439. doi: 10.1093/ije/dyx232.

4.

Increases in Thyroid Cancer Incidence and Mortality-Reply.

Kitahara CM, Devesa SS, Sosa JA.

JAMA. 2017 Jul 25;318(4):390-391. doi: 10.1001/jama.2017.7910. No abstract available.

PMID:
28742904
5.

Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F.

Am J Gastroenterol. 2017 Aug;112(8):1247-1255. doi: 10.1038/ajg.2017.155. Epub 2017 Jun 6.

PMID:
28585555
6.

Longitude Position in a Time Zone and Cancer Risk in the United States.

Gu F, Xu S, Devesa SS, Zhang F, Klerman EB, Graubard BI, Caporaso NE.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1306-1311. doi: 10.1158/1055-9965.EPI-16-1029. Epub 2017 Apr 27.

7.

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM.

JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.

PMID:
28362912
8.

Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?

Valberg M, Grotmol T, Tretli S, Veierød MB, Moger TA, Devesa SS, Aalen OO.

Eur J Epidemiol. 2017 Jun;32(6):511-520. doi: 10.1007/s10654-016-0185-z. Epub 2016 Jul 18.

9.

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM.

Br J Haematol. 2016 Aug;174(3):382-96. doi: 10.1111/bjh.14061. Epub 2016 Apr 7. Erratum in: Br J Haematol. 2017 Apr;177(2):331.

10.

International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years.

Linet MS, Brown LM, Mbulaiteye SM, Check D, Ostroumova E, Landgren A, Devesa SS.

Int J Cancer. 2016 Apr 15;138(8):1862-74. doi: 10.1002/ijc.29924. Epub 2015 Dec 21.

11.

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, Bray F, Cook MB, Devesa SS.

Int J Cancer. 2016 Mar 15;138(6):1388-400. doi: 10.1002/ijc.29894. Epub 2015 Nov 27.

12.

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior.

Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1548-56. doi: 10.1158/1055-9965.EPI-15-0044. Epub 2015 Jul 29.

13.

A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010.

Dores GM, Qubaiah O, Mody A, Ghabach B, Devesa SS.

BMC Cancer. 2015 Mar 27;15:185. doi: 10.1186/s12885-015-1188-y.

14.

Reply to US lung cancer trends by histologic type.

Lewis DR, Travis WD, Devesa SS.

Cancer. 2015 Apr 1;121(7):1152-3. doi: 10.1002/cncr.29179. Epub 2014 Dec 2. No abstract available.

15.

International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.

Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA.

Andrology. 2015 Jan;3(1):4-12. doi: 10.1111/andr.293. Epub 2014 Oct 20.

16.

Recent trends in the incidence of testicular germ cell tumors in the United States.

Ghazarian AA, Trabert B, Devesa SS, McGlynn KA.

Andrology. 2015 Jan;3(1):13-8. doi: 10.1111/andr.288. Epub 2014 Oct 20.

17.

US lung cancer trends by histologic type.

Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS.

Cancer. 2014 Sep 15;120(18):2883-92. doi: 10.1002/cncr.28749. Epub 2014 Aug 11.

18.

Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.

Wong JR, Tucker MA, Kleinerman RA, Devesa SS.

JAMA Ophthalmol. 2014 Apr 1;132(4):478-83. doi: 10.1001/jamaophthalmol.2013.8001.

PMID:
24577366
19.

Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM.

Br J Haematol. 2014 Apr;165(1):67-77. doi: 10.1111/bjh.12730. Epub 2014 Jan 12.

20.

Reply to 'Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics'.

Chow WH, Linehan WM, Devesa SS.

Cancer. 2013 Aug 15;119(16):3101. doi: 10.1002/cncr.28125. Epub 2013 May 21. No abstract available.

21.

Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS.

Cancer. 2013 Jun 15;119(12):2291-9. doi: 10.1002/cncr.27989. Epub 2013 Apr 11.

22.

Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.

Castro FA, Koshiol J, Hsing AW, Devesa SS.

Int J Cancer. 2013 Oct 1;133(7):1664-71. doi: 10.1002/ijc.28161. Epub 2013 Apr 11.

23.

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent.

Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM.

Prostate Cancer. 2013;2013:560857. doi: 10.1155/2013/560857. Epub 2013 Feb 13.

24.

Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.

Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS.

Thyroid. 2013 Jun;23(6):748-57. doi: 10.1089/thy.2012.0532. Epub 2013 May 28.

25.

Follicular thyroid cancer incidence patterns in the United States, 1980-2009.

Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, Devesa SS.

Thyroid. 2013 Aug;23(8):1015-21. doi: 10.1089/thy.2012.0356. Epub 2013 Jul 20.

26.

Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Chow WH, Shuch B, Linehan WM, Devesa SS.

Cancer. 2013 Jan 15;119(2):388-94. doi: 10.1002/cncr.27690. Epub 2012 Nov 12.

27.

State-level uterine corpus cancer incidence rates corrected for hysterectomy prevalence, 2004 to 2008.

Siegel RL, Devesa SS, Cokkinides V, Ma J, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):25-31. doi: 10.1158/1055-9965.EPI-12-0991. Epub 2012 Nov 2.

28.

Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years.

Valberg M, Grotmol T, Tretli S, Veierød MB, Devesa SS, Aalen OO.

Stat Med. 2012 Dec 10;31(28):3731-47. doi: 10.1002/sim.5441. Epub 2012 Jun 29.

29.

Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns.

Brown LM, Check DP, Devesa SS.

J Oncol. 2012;2012:649498. doi: 10.1155/2012/649498. Epub 2012 Apr 17.

30.

Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa.

Mbulaiteye SM, Anderson WF, Ferlay J, Bhatia K, Chang C, Rosenberg PS, Devesa SS, Parkin DM.

Am J Hematol. 2012 Jun;87(6):573-8. doi: 10.1002/ajh.23187. Epub 2012 Apr 10.

31.

Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States.

Little MP, Rajaraman P, Curtis RE, Devesa SS, Inskip PD, Check DP, Linet MS.

BMJ. 2012 Mar 8;344:e1147. doi: 10.1136/bmj.e1147.

32.

Trends in testicular germ cell tumors among U.S. military servicemen, 1990-2003.

Enewold L, Zhou J, Devesa SS, Erickson RL, Zhu K, McGlynn KA.

Mil Med. 2011 Oct;176(10):1184-7.

33.

Prostate cancer incidence rates in Africa.

Chu LW, Ritchey J, Devesa SS, Quraishi SM, Zhang H, Hsing AW.

Prostate Cancer. 2011;2011:947870. doi: 10.1155/2011/947870. Epub 2011 Aug 1.

34.

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM.

Blood. 2012 Jan 5;119(1):34-43. doi: 10.1182/blood-2011-04-347872. Epub 2011 Nov 15.

35.

Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Enewold LR, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zahm SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2369-76. doi: 10.1158/1055-9965.EPI-11-0596. Epub 2011 Sep 13.

36.

Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries.

Enewold L, Zhou J, McGlynn KA, Devesa SS, Shriver CD, Potter JF, Zahm SH, Zhu K.

Cancer. 2012 Mar 1;118(5):1397-403. doi: 10.1002/cncr.26208. Epub 2011 Aug 11.

37.

Sex disparities in cancer mortality and survival.

Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1629-37. doi: 10.1158/1055-9965.EPI-11-0246. Epub 2011 Jul 12.

38.

Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005).

Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, Grotmol T.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1770-7. doi: 10.1158/1055-9965.EPI-11-0136. Epub 2011 Jul 1.

39.

Assessment of follow-up, and the completeness and accuracy of cancer case ascertainment in three areas of India.

Mathew A, Daniel CR, Ferrucci LM, Seth T, Devesa SS, George PS, Shetty H, Devasenapathy N, Yurgalevitch S, Rastogi T, Prabhakaran D, Gupta PC, Chatterjee N, Sinha R.

Cancer Epidemiol. 2011 Aug;35(4):334-41. doi: 10.1016/j.canep.2011.03.006. Epub 2011 May 28.

40.

Oropharyngeal cancer incidence trends: diminishing racial disparities.

Brown LM, Check DP, Devesa SS.

Cancer Causes Control. 2011 May;22(5):753-63. doi: 10.1007/s10552-011-9748-1. Epub 2011 Mar 5.

PMID:
21380619
41.

Histological classification of liver and intrahepatic bile duct cancers in SEER registries.

Altekruse SF, Devesa SS, Dickie LA, McGlynn KA, Kleiner DE.

J Registry Manag. 2011 Winter;38(4):201-5.

42.

Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS.

Thyroid. 2011 Feb;21(2):125-34. doi: 10.1089/thy.2010.0021. Epub 2010 Dec 27.

43.

Melanoma of the skin and laterality.

Dores GM, Huycke MM, Devesa SS.

J Am Acad Dermatol. 2011 Jan;64(1):193-5; author reply 195-6. doi: 10.1016/j.jaad.2010.06.062. No abstract available.

44.

Melanoma incidence rates among whites in the U.S. Military.

Zhou J, Enewold L, Zahm SH, Devesa SS, Anderson WF, Potter JF, McGlynn KA, Zhu K.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):318-23. doi: 10.1158/1055-9965.EPI-10-0869. Epub 2010 Dec 8.

45.

Racial disparities in incidence and outcome in multiple myeloma: a population-based study.

Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, McGlynn KA, Landgren O.

Blood. 2010 Dec 16;116(25):5501-6. doi: 10.1182/blood-2010-07-298760. Epub 2010 Sep 7.

46.

AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology?

Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, Mbulaiteye SM.

Blood. 2010 Dec 16;116(25):5600-4. doi: 10.1182/blood-2010-03-275917. Epub 2010 Sep 2.

47.

Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006.

Qubaiah O, Devesa SS, Platz CE, Huycke MM, Dores GM.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1908-18. doi: 10.1158/1055-9965.EPI-10-0328. Epub 2010 Jul 20.

48.

Brain cancer incidence trends in relation to cellular telephone use in the United States.

Inskip PD, Hoover RN, Devesa SS.

Neuro Oncol. 2010 Nov;12(11):1147-51. doi: 10.1093/neuonc/noq077. Epub 2010 Jul 16.

49.

Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study.

Blake PW, Bradford PT, Devesa SS, Toro JR.

Arch Dermatol. 2010 Jun;146(6):625-32. doi: 10.1001/archdermatol.2010.105.

PMID:
20566926
50.

Sex disparities in colorectal cancer incidence by anatomic subsite, race and age.

Murphy G, Devesa SS, Cross AJ, Inskip PD, McGlynn KA, Cook MB.

Int J Cancer. 2011 Apr 1;128(7):1668-75. doi: 10.1002/ijc.25481. Epub 2010 May 25.

Supplemental Content

Loading ...
Support Center